indapamide has been researched along with Cerebrovascular Disorders in 13 studies
Indapamide: A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
indapamide : A sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) showed that blood pressure lowering reduced stroke risk in patients with a history of cerebrovascular events." | 9.11 | Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. ( Anderson, C; Bousser, MG; Chalmers, J; Chapman, N; Colman, S; Davis, S; Donnan, G; Huxley, R; MacMahon, S; Neal, B; Warlow, C; Woodward, M, 2004) |
| "The primary aim of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) is to determine the effects of a long-term angiotensin converting enzyme (ACE)-inhibitor-based blood-pressure-lowering regimen on the risk of stroke among patients with a history of stroke or transient ischaemic attack (TIA)." | 9.09 | PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee. ( , 1999) |
| "The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) showed that blood pressure lowering reduced stroke risk in patients with a history of cerebrovascular events." | 5.11 | Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. ( Anderson, C; Bousser, MG; Chalmers, J; Chapman, N; Colman, S; Davis, S; Donnan, G; Huxley, R; MacMahon, S; Neal, B; Warlow, C; Woodward, M, 2004) |
| "Among individuals with cerebrovascular disease, a perindopril-based blood pressure-lowering regimen not only reduced the risk of stroke and major vascular events but also substantially reduced the risks of associated long-term disability and dependency." | 5.10 | Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial. ( Anderson, C; Chalmers, J; Chapman, N; Davis, S; Fransen, M; MacMahon, S; Neal, B; Sega, R; Terent, A; Tzourio, C; Woodward, M, 2003) |
| "The primary aim of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) is to determine the effects of a long-term angiotensin converting enzyme (ACE)-inhibitor-based blood-pressure-lowering regimen on the risk of stroke among patients with a history of stroke or transient ischaemic attack (TIA)." | 5.09 | PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee. ( , 1999) |
| "5 mg SR formulation of indapamide has an improved antihypertensive efficacy : safety ratio, which is in accordance with international recommendations for the use of low-dose antihypertensive drugs and diuretics in first-line therapy of hypertension." | 5.08 | Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group. ( Ambrosioni, E; de Cordoüe, A; Degaute, JP; Guez, D; MacMahon, M; Malin, PL; Pujol, DR; Safar, M, 1998) |
| "Hyperlipidemia is a widely acknowledged side effect of thiazide diuretic therapy, but it is often dismissed as a short-term effect of high-dose therapy." | 2.40 | Hyperlipidemia of diuretic therapy. ( Ames, R, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (69.23) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afanas'ev, IuI | 1 |
| Storozhenko, SIu | 1 |
| Grigorova, SIu | 1 |
| Tzourio, C | 2 |
| Anderson, C | 3 |
| Chapman, N | 3 |
| Woodward, M | 3 |
| Neal, B | 3 |
| MacMahon, S | 3 |
| Chalmers, J | 3 |
| Fransen, M | 1 |
| Davis, S | 2 |
| Sega, R | 1 |
| Terent, A | 1 |
| Huxley, R | 1 |
| Bousser, MG | 1 |
| Colman, S | 1 |
| Donnan, G | 1 |
| Warlow, C | 1 |
| Contard, F | 1 |
| Sabri, A | 1 |
| Glukhova, M | 1 |
| Sartore, S | 1 |
| Marotte, F | 1 |
| Pomies, JP | 1 |
| Schiavi, P | 1 |
| Guez, D | 2 |
| Samuel, JL | 1 |
| Rappaport, L | 1 |
| Levy, BI | 1 |
| Poitevin, P | 1 |
| Duriez, M | 1 |
| Guez, DC | 1 |
| Schiavi, PD | 1 |
| Safar, ME | 1 |
| Biagini, G | 2 |
| Zoli, M | 1 |
| Torri, C | 1 |
| Boschi, S | 1 |
| Vantaggiato, G | 1 |
| Ballestri, M | 1 |
| Baraldi, A | 1 |
| Agnati, LF | 1 |
| Ames, R | 1 |
| Razzetti, R | 1 |
| Bongrani, S | 1 |
| Oberto, G | 1 |
| Ferrari, R | 1 |
| Ambrosioni, E | 1 |
| Safar, M | 1 |
| Degaute, JP | 1 |
| Malin, PL | 1 |
| MacMahon, M | 1 |
| Pujol, DR | 1 |
| de Cordoüe, A | 1 |
1 review available for indapamide and Cerebrovascular Disorders
| Article | Year |
|---|---|
Hyperlipidemia of diuretic therapy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cere | 1998 |
7 trials available for indapamide and Cerebrovascular Disorders
| Article | Year |
|---|---|
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cerebrovasc | 2003 |
Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial.
Topics: Activities of Daily Living; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood | 2003 |
Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Brain Ische | 2004 |
Post-stroke antihypertensive treatment study. A preliminary result.
Topics: Aged; Antihypertensive Agents; Cerebrovascular Disorders; China; Double-Blind Method; Female; Humans | 1995 |
PROGRESS: Perindopril pROtection aGainst REcurrent Stroke Study: status in March 1997. PROGRESS Management Committee.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cerebrovascular Disorders; Diuretics; Double-Blind M | 1998 |
Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group.
Topics: Adult; Aged; Angina Pectoris; Antihypertensive Agents; Blood Pressure; Cerebrovascular Disorders; De | 1998 |
PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cerebrovascular Disorders; Diuretics | 1999 |
5 other studies available for indapamide and Cerebrovascular Disorders
| Article | Year |
|---|---|
[Potentialities of medicinal correction of cerebrovascular disturbances in patients with arterial hypertension].
Topics: Amlodipine; Antihypertensive Agents; Bisoprolol; Cerebrovascular Disorders; Drug Therapy, Combinatio | 2012 |
Arterial smooth muscle cell phenotype in stroke-prone spontaneously hypertensive rats.
Topics: Actins; Animals; Aorta, Thoracic; Cerebral Cortex; Cerebrovascular Disorders; Fibronectins; Hydrochl | 1993 |
Sodium, survival, and the mechanical properties of the carotid artery in stroke-prone hypertensive rats.
Topics: Animals; Blood Pressure; Body Weight; Carotid Artery, Common; Cerebrovascular Disorders; Collagen; D | 1997 |
Protective effects of delapril, indapamide and their combination chronically administered to stroke-prone spontaneously hypertensive rats fed a high-sodium diet.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bl | 1997 |
Protective effects of delapril, indapamide and their combination on stroke occurrence and lifespan in salt-loaded stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cerebrovascular Disorders; Diuretics | 1998 |